SCHEMBL6771771

SCHEMBL6771771

CC(C)Cc1ccc(-c2ccccc2S(=O)(=O)n2cccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 2/20 0.52
EDNRB P24530 1/20 0.52
OPRM1 P35372 8/20 0.49
OPRK1 P41145 8/20 0.49
KCNH2 Q12809 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772781 0.80 EDNRA (0.53) EDNRAEDNRBOPRM1OPRK1KCNH2
SCHEMBL6776216 0.80 EDNRA (0.53) EDNRAEDNRBOPRM1OPRK1KCNH2
SCHEMBL6777874 0.80 EDNRA (0.53) EDNRAEDNRBOPRM1OPRK1KCNH2
SCHEMBL9572126 0.78 EDNRA (0.52) EDNRAEDNRBOPRM1OPRK1KCNH2
SCHEMBL6771873 0.75 EDNRA (0.58) EDNRAEDNRBOPRM1OPRK1KCNH2
SCHEMBL8755224 0.69 PPARA (0.54) EDNRAEDNRB
SCHEMBL6778007 0.69 EDNRA (1.00) EDNRAEDNRB
SCHEMBL8632293 0.69 KMT2A (0.46) EDNRAEDNRB
SCHEMBL27361342 0.69 PPARG (0.50) EDNRAEDNRB
SCHEMBL8055287 0.68 EDNRA (0.58) EDNRAEDNRBOPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673824-B1 HYPOTENSIVE AGENTS BRISTOL-MYERS SQUIBB CO. 2004-01-06 US disclosed
US-6107320-A Phenyl sulfonamide endothelin antagonists BRISTOL-MYERS SQUIBB CO. (US) 2000-08-22 US disclosed
EP-0569193-B1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists SQUIBB & SONS INC (US) 1997-02-26 EP disclosed
US-5514696-A Phenyl sulfonamide endothelin antagonists BRISTOL-MYERS SQUIBB CO. (US) 1996-05-07 US disclosed
EP-0569193-A1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists E.R. SQUIBB & SONS, INC. (US) 1993-11-10 EP disclosed